Market Approach
Despite the urgent need for improved care in growing markets (both domestically and internationally), community-based healthcare providers face high barriers to the implementation of new technologies, including substantial capital requirements, limited technological know-how and local politics. Many international regions lack a formal training program for medical physicists and dosimetrists, and often even physicians are undertrained on the newest technologies.
CTSI intends to become the market leader in each region it enters through providing superior equipment technology, patient outcomes research, clinical protocols for advanced conformal radiation therapy, pathway-driven medical oncology treatment and overall satisfaction of its patients and referring physicians. CTSI’s business model addresses the dynamics driving development in the oncology services market worldwide.
- Patient Focus - Superior patient care is second to none, allowing for a full range of outpatient cancer services to be provided in a comfortable setting and convenient, local location.
- Constant Innovation - Treatment of cancer utilizing leading edge modalities is becoming increasingly complex given the rapid expansion of efficacious chemotherapeutic agents, biologically targeted therapies, highly conformal radiation delivery, minimally invasive procedures and complex supportive regimens;
- Infastructure Limitations - New therapies are expensive, often use more than one modality, are rapidly changing, require initial and ongoing training of healthcare professionals, require a team approach and often take years to transition to the community setting from large university hospitals;
- Increasing Demand - Patients and their families, through education via the Internet and other sources, demand that new therapies be provided locally or will travel great distances to get them;
- Support - Without centralization of process for many of its core functions, a stand-alone facility will have difficulty accessing necessary capital, hiring and retaining the necessary expertise and managing its ongoing clinical and business functions; and
- Execution - First-mover advantage, economies of scale and scope, centralization of certain critical processes, oncology expertise, and initial and ongoing training of all levels of personnel will ensure quality of care within an ongoing profitable, non-university business model.
